Class information for:
Level 1: DONEPEZIL//RIVASTIGMINE//MEMANTINE

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
2852 2057 37.9 74%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
51 29009 DEMENTIA//MILD COGNITIVE IMPAIRMENT//ALZHEIMERS DISEASE

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 DONEPEZIL Author keyword 145 37% 15% 311
2 RIVASTIGMINE Author keyword 112 45% 9% 187
3 MEMANTINE Author keyword 110 31% 15% 299
4 GALANTAMINE Author keyword 103 44% 9% 177
5 CHOLINESTERASE INHIBITORS Author keyword 47 25% 8% 166
6 GLENPOINTE W Address 25 75% 1% 18
7 SEVERE IMPAIRMENT BATTERY Author keyword 21 85% 1% 11
8 CHOLINESTERASE INHIBITOR Author keyword 16 21% 3% 66
9 RIVASTIGMINE PATCH Author keyword 11 100% 0% 6
10 ACETYLCHOLINESTERASE INHIBITORS Author keyword 10 15% 3% 61

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 DONEPEZIL 145 37% 15% 311 Search DONEPEZIL Search DONEPEZIL
2 RIVASTIGMINE 112 45% 9% 187 Search RIVASTIGMINE Search RIVASTIGMINE
3 MEMANTINE 110 31% 15% 299 Search MEMANTINE Search MEMANTINE
4 GALANTAMINE 103 44% 9% 177 Search GALANTAMINE Search GALANTAMINE
5 CHOLINESTERASE INHIBITORS 47 25% 8% 166 Search CHOLINESTERASE+INHIBITORS Search CHOLINESTERASE+INHIBITORS
6 SEVERE IMPAIRMENT BATTERY 21 85% 1% 11 Search SEVERE+IMPAIRMENT+BATTERY Search SEVERE+IMPAIRMENT+BATTERY
7 CHOLINESTERASE INHIBITOR 16 21% 3% 66 Search CHOLINESTERASE+INHIBITOR Search CHOLINESTERASE+INHIBITOR
8 RIVASTIGMINE PATCH 11 100% 0% 6 Search RIVASTIGMINE+PATCH Search RIVASTIGMINE+PATCH
9 ACETYLCHOLINESTERASE INHIBITORS 10 15% 3% 61 Search ACETYLCHOLINESTERASE+INHIBITORS Search ACETYLCHOLINESTERASE+INHIBITORS
10 ADAS COG 10 36% 1% 22 Search ADAS+COG Search ADAS+COG

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 DONEPEZIL 165 33% 20% 407
2 CHOLINESTERASE INHIBITORS 72 25% 12% 254
3 RIVASTIGMINE 61 33% 8% 156
4 GALANTAMINE 57 33% 7% 142
5 GLOBAL FUNCTION 56 61% 3% 59
6 SEVERE IMPAIRMENT BATTERY 50 71% 2% 40
7 ALREADY RECEIVING DONEPEZIL 49 94% 1% 17
8 US MULTICENTER 40 59% 2% 45
9 SEVERE ALZHEIMERS DISEASE 40 43% 3% 71
10 24 WEEK 35 46% 3% 57

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Cholinesterase inhibitors for Alzheimer's disease 2006 439 36 72%
Effectiveness of cholinesterase inhibitors and memantine for treating dementia: Evidence review for a clinical practice guideline 2008 257 125 56%
Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: A systematic review and meta-analysis 2008 124 55 78%
Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer's Disease 2013 25 100 57%
Memantine for dementia 2006 183 33 67%
Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutarnatergic system - too little activation is bad, too much is even worse 2007 246 206 34%
Donepezil for dementia due to Alzheimer's disease (Review) 2006 173 51 61%
A review of the effects of memantine on clinical progression in Alzheimer's disease 2012 15 33 91%
Effective pharmacologic management of Alzheimer's disease 2007 99 53 62%
The effects of donepezil in Alzheimer's disease - Results from a multinational trial 1999 352 19 79%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 GLENPOINTE W 25 75% 0.9% 18
2 CLIN ALZHEIMERS DIS RELATED DISORDERS 9 64% 0.4% 9
3 MEMORY ASSESSMENT 6 30% 0.8% 17
4 ARBEITSGRP GERONTOPSYCHIAT 5 63% 0.2% 5
5 CNS AREA 4 67% 0.2% 4
6 ALZHEIMERS DIS MANAGEMENT TEAM 4 75% 0.1% 3
7 MCGILL STUDIES AGING 4 16% 1.1% 22
8 BIOMETR BIOSTAT 3 57% 0.2% 4
9 ALZHEIMERS DIS MEMORY DISORDERS 3 23% 0.6% 12
10 DEMENTIA INTERVENT GRP 3 50% 0.2% 4

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000251157 RUD//INFORMAL CARE//CARERQOL INSTRUMENT
2 0.0000169046 EARLY ONSET DEMENTIA//RAPID COGNITIVE DECLINE//YOUNG ONSET DEMENTIA
3 0.0000163518 TACRINE//TETRAHYDROAMINOACRIDINE//METRIFONATE
4 0.0000121288 RIMANTADINE//AMANTADINE HCL//MEMANTINE HYDROCHLORIDE
5 0.0000111082 BPSD//NEUROPSYCHIATRIC SYMPTOMS//BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA
6 0.0000091278 MEMORY CLINICS//MEMORY CLINIC//DEMENTIA CARE MANAGEMENT
7 0.0000089685 BIS7 TACRINE//BUTYRYLCHOLINESTERASE//ACETYLCHOLINESTERASE INHIBITORS
8 0.0000086479 MILD COGNITIVE IMPAIRMENT//AD8//MCI
9 0.0000073158 VASCULAR DEMENTIA//POSTSTROKE DEMENTIA//VASCULAR COGNITIVE IMPAIRMENT
10 0.0000067140 MINI MENTAL STATE EXAMINATION//DEMENTIA INCIDENCE//DEMENTIA PREVALENCE